Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2010-08-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Perioperative Hb Monitoring in Spinal Surgery
NCT02908412
The Influence of a Bupivacaine Digital Nerve Block Using Rev G.
NCT01750554
Hemodynamic Effect of Lumbosacral Plexus Blockade Versus Spinal Anesthesia
NCT02544269
Lumbar ESPB in Hip Replacement Surgery
NCT06282666
Compare Epidural vs. Lumbar Plexus Analgesia After Hip Arthroplasty
NCT02493621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb) following the digital block.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Digital block
Lidocaine digital block
One dose of lidocaine 2% injected locally into one finger (2 mls total)
Masimo SpHb continuous hemoglobin monitor
Masimo SpHb continuous hemoglobin monitor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine digital block
One dose of lidocaine 2% injected locally into one finger (2 mls total)
Masimo SpHb continuous hemoglobin monitor
Masimo SpHb continuous hemoglobin monitor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA Classification 1, 2 or 3
* Scheduled to undergo spine or hip revision surgery
Exclusion Criteria
* Patients who in the study investigators clinical judgement would not be suitable for research.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronald D Miller, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Francisco
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-00524B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.